RIPRETINIB for Malignant connective tissue neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 139 adverse event reports in the FDA FAERS database where RIPRETINIB was used for Malignant connective tissue neoplasm.

Most Reported Side Effects for RIPRETINIB

Side Effect	Reports	%	Deaths	Hosp.
Fatigue	582	13.1%	17	86
Alopecia	517	11.7%	7	66
Extra dose administered	357	8.1%	32	65
Death	356	8.0%	356	63
Underdose	345	7.8%	19	67
Nausea	292	6.6%	11	62
Drug ineffective	291	6.6%	15	53
Disease progression	290	6.5%	67	48
Hospitalisation	280	6.3%	26	280
Neoplasm progression	263	5.9%	20	49
Constipation	249	5.6%	15	50
Pain	247	5.6%	14	62
Diarrhoea	238	5.4%	4	37
Muscle spasms	221	5.0%	2	30
Adverse event	214	4.8%	5	36